Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain

scientific article published in June 1989

Gangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1039989503
P356DOI10.1007/BF00999386
P698PubMed publication ID2547146

P2093author name stringM Adachi
S E Brooks
L Schneck
M R Stein
L M Hoffman
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
Enzyme alterations and lipid storage in three variants of Tay-Sachs diseaseQ28250636
DETECTION OF SPECIFIC ANTIGEN IN SV40-TRANSFORMED CELLS BY IMMUNOFLUORESCENCEQ36266598
Structures and organization of cell surface glycolipids dependency on cell growth and malignant transformationQ36373116
Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectivesQ39817695
Cytology, growth characteristics and cellular alterations following SV40-induced transformation of human foetal brain cells derived from a Gm2 gangliosidosis and controlQ40281154
An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materialsQ41826978
Molecular Forms of beta-N-Acetylhexosaminidase in Epstein-Barr Virus-Transformed Lymphoid Cell Lines from Normal Subjects and Patients with Tay-Sachs DiseaseQ45798300
Glycosphingolipids in fetal Tay-Sachs disease brain and lung culturesQ48267993
A murine monoclonal antibody detecting N-acetyl- and N-glycolyl-GM2: characterization of cell surface reactivityQ48315365
GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the diseaseQ48375488
Tay-Sachs disease and normal cerebellar cells in culture: elevated levels of lysosomal enzymes in Tay-Sachs disease cellsQ49088829
The pattern of mammalian brain gangliosides. II. Evaluation of the extraction procedures, postmortem changes and the effect of formalin preservationQ51250426
CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES*Q51283844
In vitro establishment of human fibroblasts of lysosomal diseases, GM1-gangliosidosis and Sandhoff disease, by transformation with origin-minus SV40 DNA.Q53545480
Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.Q54448606
A densitometric method for the determination of gangliosides after their separation by thin-layer chromatography and detection with resorcinol reagentQ69630461
GM2-ganglioside metabolism in cultured human skin fibroblasts: unambiguous diagnosis of GM2-gangliosidosisQ70105251
Glycosphingolipids in cultured human skin fibroblasts. II. Characterization and metabolism in fibroblasts from patients with inborn errors of glycosphingolipid and mucopolysaccharide metabolismQ70445223
Long-term intracellular retention of hexosaminidase A by Tay-Sachs disease brain and lung cells in vitroQ70558717
Ganglioside accumulation in cultured skin fibroblasts from gangliosidosis patientsQ71137381
Enzyme replacement treatment for Tay-Sachs disease brain cells in culture utilizing concanavalin A-mediated hexosaminidase A uptake: biochemical and morphological evidence of GM2 mobilizationQ71201241
Tay-Sachs disease brain cells in culture: mobilization of stored GM2 after concanavalin A-mediated uptake of hexosaminidase AQ71406009
Human fetal brain cells in culture. Increase in GM2 ganglioside after SV-40 transformationQ72911055
P4510describes a project that usesNG125Q54930458
P433issue2
P921main subjectTay-Sachs diseaseQ560337
cell lineQ21014462
P304page(s)87-93
P577publication date1989-06-01
P1433published inMetabolic Brain DiseaseQ15764352
P1476titleGangliosides in SV-40-transformed cells derived from Tay-Sachs disease fetal brain
P478volume4

Reverse relations

Q54930458NG125described by sourceP1343
Q39367263Ganglioside biosynthesis in developing brains and apoptotic cancer cells: X. regulation of glyco-genes involved in GD3 and Sialyl-Lex/a synthesescites workP2860

Search more.